Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. Home/
    2. Perspectives & insights

    Perspectives & insights

    Dive deep into our latest commentary on policy issues.

    Featured

    View all
    Perspectives & insights
    July 17, 2026

    HRSA finds 340B covered entity purchases have eclipsed $100 billion

    Read more
    Perspectives & insights
    June 23, 2026

    How should drug prices be specified in U.S. economic analyses?

    Read more
    Perspectives & insights
    June 17, 2026

    How have new medicines improved health and life expectancy in the United States?

    This is the first blog of a three-part series highlighting the Value of Health in the United States.
    Read more
    Perspectives & insights
    May 11, 2026

    Blog: The value of medicines in the U.S.

    Read more
    Perspectives & insights
    March 25, 2026

    Who’s driving the surge in the 340B Program?

    Read more
    Perspectives & insights
    March 11, 2026

    Perspective matters: The importance of understanding lived experience in considering the value of treatment

    Read more
    Perspectives & insights
    March 6, 2026

    Minnesota finds large hospital systems collect most 340B profits, while middlemen siphon off tens of millions

    Read more